Home » January / February 2022 » European APIs producers: key role in the future scenario of health system
2022 | January / February 2022

European APIs producers: key role in the future scenario of health system

by cyb2025
G. F. Baccalini
APIs
Asia
EUROPE
green chemistry
new technologies
pandemic
Reshoring

GIAN MARIO BACCALINI
EFCG Board member, Brussels, Belgium, Aschimfarma Past President, Milan, Italy
Bulk & Pharma Development President, Milan, Italy

ABSTRACT

There are many problems in Europe related to the normal distribution and production of essential drugs, due to the shortage of APIs (Active pharmaceutical ingredient) and key intermediates utilized in the synthesis of API. These products are mainly coming from Asia, particularly from China, that, during the last years had to face many problems related to the imposed shutdown of many factories.
The situation is more and more difficult, but there are solutions. With good politics, good industrial actions plans and a careful vision of the future, including not only our needs, but the worldwide needs, we can overcome the current difficulties, and, even more important, to be prepared to other crisis.

Pandemic highlighted that there are many problems in Europe related to the normal distribution of essential drugs. This is basically related to the shortage of active pharmaceutical ingredient (API).

ABOUT THE AUTHOR

Gian Mario Baccalini – Long experience in API and Pharmaceuticals field, as top manager in many Companies, and entrepreneur. Dedicated for many years to the category associations’ activity, in leader positions, either in Italy, either in Europe, and being part of the institutional discussion and decision tables. Many results were achieved, that brought the world of API producers out of the shadows. Strong interest and participation in promoting advanced technologies to apply to new and old productions, to have a more sustainable chemistry.

Latest issue

November /December 2025

View Issue

Archive

For an even more in-depth scientific analysis, consult the archive

Chemistry Today - Archive
Go to archive

Content from magazine

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.
View all content

Most popular

@2026 - All Right Reserved.

Login